Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance
The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.
Read More
Search Results for: lung cancer
First Ascent Biomedical Opens Cancer Testing Lab in Miami
The CLIA-certified facility offers functional precision medicine testing that analyzes live tumor cells against FDA-approved therapies within 10 days.
Read More
FDA Approves PD-L1 Test to Guide Immunotherapy in Ovarian and Related Cancers
PD-L1 testing is now cleared to help identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who may be eligible for anti–PD-1 therapy.
Read More
Hims & Hers Adds Multi-Cancer Blood Test to Digital Health Platform
Hims & Hers Health is now offering GRAIL’s Galleri multi-cancer blood test through its digital health platform, expanding access to screening for more than 50 cancer types, including those lacking established protocols.
Read More
Blood Test Detects Early-Stage Cancer Using DNA Methylation Patterns
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
Read More